Literature DB >> 15767854

Regulation of SR-BI-mediated high-density lipoprotein metabolism by the tissue-specific adaptor protein PDZK1.

Ayce Yesilaltay1, Olivier Kocher, Attilio Rigotti, Monty Krieger.   

Abstract

PURPOSE OF REVIEW: A novel mechanism for the regulation of lipoprotein receptor activity is providing new insights into the control of lipid metabolism. The tissue-specific adaptors ARH (autosomal recessive hypercholesterolemia) and PDZK1 [where PDZ derives from postsynaptic density protein (PSD-95)/Drosophila discs-large (dlg)/tight-junction protein (ZO1)] have been shown to control the activities of distinct types of lipoprotein receptors in a posttranscriptional fashion, significantly affecting overall lipoprotein metabolism. This review will focus on one of these lipoprotein receptor-adaptor pairs, the high-density lipoprotein receptor SR-BI (scavenger receptor class B, type I) and its adaptor PDZK1. RECENT
FINDINGS: The PDZ domain-containing adaptor protein PDZK1 has been shown to bind to and control the activity of the high-density lipoprotein receptor SR-BI via a tissue-specific posttranscriptional mechanism. Mice deficient in PDZK1 have elevated plasma cholesterol levels due to the virtually complete hepatic ablation of SR-BI, implicating PDZK1 as a novel regulator of high-density lipoprotein metabolism.
SUMMARY: The functions of ARH and PDZK1 suggest that other adaptor proteins may be found to control the activities of other cell-surface receptors in a similar tissue-specific fashion. Manipulation of the expression and/or activities of such adaptors might provide new insights into receptor physiology and these adaptors may prove to be attractive targets for pharmaceutical intervention in cholesterol metabolism-related disease processes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767854     DOI: 10.1097/01.mol.0000162319.54795.e5

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  18 in total

1.  Noncanonical role of the PDZ4 domain of the adaptor protein PDZK1 in the regulation of the hepatic high density lipoprotein receptor scavenger receptor class B, type I (SR-BI).

Authors:  Kosuke Tsukamoto; Thomas E Wales; Kathleen Daniels; Rinku Pal; Ren Sheng; Wonhwa Cho; Walter Stafford; John R Engen; Monty Krieger; Olivier Kocher
Journal:  J Biol Chem       Date:  2013-05-17       Impact factor: 5.157

2.  MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition.

Authors:  Li Wang; Xiao-Jian Jia; Hua-Jun Jiang; Yu Du; Fan Yang; Shu-Yi Si; Bin Hong
Journal:  Mol Cell Biol       Date:  2013-03-04       Impact factor: 4.272

3.  D-AKAP2:PKA RII:PDZK1 ternary complex structure: insights from the nucleation of a polyvalent scaffold.

Authors:  Ganapathy N Sarma; Issa S Moody; Ronit Ilouz; Ryan H Phan; Banumathi Sankaran; Randy A Hall; Susan S Taylor
Journal:  Protein Sci       Date:  2014-12-05       Impact factor: 6.725

4.  In vitro and in vivo analysis of the binding of the C terminus of the HDL receptor scavenger receptor class B, type I (SR-BI), to the PDZ1 domain of its adaptor protein PDZK1.

Authors:  Olivier Kocher; Gabriel Birrane; Kosuke Tsukamoto; Sara Fenske; Ayce Yesilaltay; Rinku Pal; Kathleen Daniels; John A A Ladias; Monty Krieger
Journal:  J Biol Chem       Date:  2010-08-25       Impact factor: 5.157

5.  Identification of the PDZ3 domain of the adaptor protein PDZK1 as a second, physiologically functional binding site for the C terminus of the high density lipoprotein receptor scavenger receptor class B type I.

Authors:  Olivier Kocher; Gabriel Birrane; Ayce Yesilaltay; Sharon Shechter; Rinku Pal; Kathleen Daniels; Monty Krieger
Journal:  J Biol Chem       Date:  2011-05-23       Impact factor: 5.157

Review 6.  Hepatic high-density lipoprotein receptors: roles in lipoprotein metabolism and potential for therapeutic modulation.

Authors:  Bernardo L Trigatti
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

7.  Carboxy-terminal deletion of the HDL receptor reduces receptor levels in liver and steroidogenic tissues, induces hypercholesterolemia, and causes fatal heart disease.

Authors:  Rinku Pal; Qingen Ke; German A Pihan; Ayce Yesilaltay; Marsha L Penman; Li Wang; Chandramohan Chitraju; Peter M Kang; Monty Krieger; Olivier Kocher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-30       Impact factor: 4.733

Review 8.  Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI.

Authors:  Olivier Kocher; Monty Krieger
Journal:  Curr Opin Lipidol       Date:  2009-06       Impact factor: 4.776

9.  Novel ENU-induced point mutation in scavenger receptor class B, member 1, results in liver specific loss of SCARB1 protein.

Authors:  Ioannis M Stylianou; Karen L Svenson; Sara K VanOrman; Yanina Langle; John S Millar; Beverly Paigen; Daniel J Rader
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

10.  Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice.

Authors:  Ayce Yesilaltay; Kathleen Daniels; Rinku Pal; Monty Krieger; Olivier Kocher
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.